{
    "clinical_study": {
        "@rank": "4964", 
        "arm_group": [
            {
                "arm_group_label": "Fermented blueberry product", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Probiotic bacteria", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study was to examine the efficacy of a probiotic-based product on\n      either reducing hypertension or preventing a high normal blood pressure from reaching\n      hypertensive levels."
        }, 
        "brief_title": "Effect of a Probiotic-based Product on Blood Pressure", 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Blood Pressure", 
        "condition_browse": {
            "mesh_term": "Cardiovascular Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy individuals at the age of 40-75 years.\n\n          -  Blood-pressure >140/90 mmHg that has been confirmed at 2-3 separate occasions or\n             represents the mean value of a 24-hour measurement.\n\n          -  Triglycerides >1,7 mmol/L and/or HDL <1 mmol/L (men)/1,29 mmol/L (women).\n\n          -  Fasting plasma glucose levels >5,6 mmol/L and/or waist circumference >102 cm (men)/88\n             cm (women).\n\n          -  BMI <40.\n\n        Exclusion Criteria:\n\n          -  Medically treated allergy or allergy to any of the ingredients of the study product.\n\n          -  Medication for high levels of blood lipids.\n\n          -  Metabolic disease, such as type one diabetes.\n\n          -  Confirmed diseases of the heart, liver of kidneys.\n\n          -  Chronic inflammatory disease requiring medication.\n\n          -  Pregnant or nursing.\n\n          -  Regular intake of other probiotic products (5-7 days per week during the last three\n             months before inclusion into the study)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "142", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01989702", 
            "org_study_id": "ProMeta"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fermented blueberry product", 
                "intervention_name": "Fermented blueberry drink", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Placebo", 
                    "Probiotic bacteria"
                ], 
                "intervention_name": "Placebo drink", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Probiotic bacteria", 
                "intervention_name": "Sachets with probiotic bacterial powder", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Fermented blueberry product", 
                    "Placebo"
                ], 
                "intervention_name": "Sachets with placebo powder", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Malm\u00f6", 
                    "country": "Sweden"
                }
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effect of a Probiotic-based Product on Blood Pressure and Other Known Risk Factors Linked to Cardiovascular Diseases.", 
        "other_outcome": {
            "measure": "Effect of study product on intestinal microbiota as analysed in fecal samples", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 3 months"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sweden: Ethical review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Changes from baseline in systolic and diastolic blood pressure after 3 months of probiotic intervention", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01989702"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Changes from baseline of blood parameters, such as inflammatory markers and blood lipids, linked to increased risk for cardiovascular diseases", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 3 months"
        }, 
        "source": "Probi AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Probi AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}